The Surprising Side Effect of GLP-1 Weight Loss Drugs: Scurvy
The popular weight-loss drugs GLP-1 have been linked to a surprising and potentially dangerous side effect: scurvy. This condition, once prevalent among sailors in the 18th century, is now making a comeback due to the extreme appetite suppression these drugs induce. Researchers warn that some users are consuming too little nutrient-dense food, leading to vitamin deficiencies that can impact bone, brain, gut, skin health, and muscle mass. According to the Mayo Clinic, scurvy, caused by severe vitamin C deficiency, can result in anemia, bleeding gums, easy bruising, and slow wound healing.
A concerning case was reported by musician Robbie Williams, who revealed he developed scurvy after taking a medication similar to Ozempic. He stopped eating, leading to a lack of essential nutrients. A review from Australia's University of Newcastle analyzed 41 controlled GLP-1 trials involving 50,000 people over 17 years and found a startling lack of focus on nutrition. Only two studies evaluated overall nutrition, and only one published the results. This highlights a critical gap in our understanding of the long-term effects of these drugs.
Clare Collins, a nutrition and dietetics professor, emphasizes the importance of nutrition in health. She notes that when people eat less, the quality of their diet becomes even more crucial. Collins urges health systems to address the issue of deficiencies before they become widespread. She advocates for general practitioners to include routine referrals to dietitians in their chronic disease plans for GLP-1 users, ensuring that patients receive the necessary guidance on maintaining a balanced diet.
This issue raises important questions about the potential risks associated with weight-loss drugs and the need for comprehensive research and patient education. As these drugs become more popular, it is crucial to address the nutritional implications to ensure patient safety and well-being.
